What is the opinion of the Work Group on the risks and benefits of RASi therapy?
In the opinion of the Work Group, most well-informed patients with CKD and severely increased albuminuria would place emphasis on preventing CV outcomes in addition to preventing CKD progression. The risks, benefits, resource use, and costs of RASi therapy should be considered when treating patients with CKD.